Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
暂无分享,去创建一个
J. Karbach | Y. Kanakura | D. Sugiyama | S. Sakaguchi | E. Sato | I. Katayama | E. Jäger | A. Tanemura | Y. Maeda | H. Nishikawa | S. Ezoe | Y. Fukumori | M. Nishioka